Radiotherapy as a mainstay of in-depth cervical cancer (CC) treatment suffers from its radioresistance. Radiodynamic therapy (RDT) effectively reverses radio-resistance by generating reactive oxygen species (ROS) with deep tissue penetration. However, the photosensitizers stimulated by X-ray have high toxicity and energy attenuation. Therefore, X-ray responsive diselenide-bridged mesoporous silica nanoparticles (DMSNs) are designed, loading X-ray-activated photosensitizer acridine orange (AO) for spot blasting RDT like Trojan-horse against radio-resistance cervical cancer (R-CC). DMSNs can encapsulate a large amount of AO, in the tumor microenvironment (TME), which has a high concentration of hydrogen peroxide, X-ray radiation triggers the cleavage of diselenide bonds, leading to the degradation of DMSNs and the consequent release of AO directly at the tumor site. On the one hand, it solves the problems of rapid drug clearance, adverse distribution, and side effects caused by simple AO treatment. On the other hand, it fully utilizes the advantages of highly penetrating X-ray responsive RDT to enhance radiotherapy sensitivity. This approach results in ROS-induced mitochondria damage, inhibition of DNA damage repair, cell cycle arrest and promotion of cancer cell apoptosis in R-CC. The X-ray responsive DMSNs@AO hold considerable potential in overcoming obstacles for advanced RDT in the treatment of R-CC.
Keyphrases
- high resolution
- dual energy
- dna damage
- reactive oxygen species
- hydrogen peroxide
- cell death
- oxidative stress
- early stage
- photodynamic therapy
- cell cycle arrest
- electron microscopy
- mental health
- cancer therapy
- radiation induced
- computed tomography
- radiation therapy
- magnetic resonance imaging
- young adults
- papillary thyroid
- drug delivery
- stem cells
- magnetic resonance
- risk assessment
- climate change
- mesenchymal stem cells
- mass spectrometry
- signaling pathway
- transcription factor
- squamous cell
- pi k akt
- adverse drug
- walled carbon nanotubes